Telling this story induces so much backlash that I typically just tell an incentive story unless financial reform itself is the core issue we are discussing.
One colleague, who is knowledgeable about both IARC and the National Cancer Institute group, offered that scientists involved in this contentious issue have a strong incentive to keep a low profile.